These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1986150

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma. Analysis at the eighth year.
    Takita H, Hollinshead A, Hart T, Bhayana J, Adler R, Rao U, Moskowitz R, Ramundo M.
    Cancer Immunol Immunother; 1985; 20(3):231-5. PubMed ID: 3904977
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M, Kocher T, Adamina M, Guller U, Dalquen P, Haas P, Mirlacher M, Gambazzi F, Harder F, Heberer M, Sauter G, Spagnoli GC.
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
    Koshy M, Fedewa SA, Malik R, Ferguson MK, Vigneswaran WT, Feldman L, Howard A, Abdelhady K, Weichselbaum RR, Virgo KS.
    J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
    [Abstract] [Full Text] [Related]

  • 13. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy.
    Lee H, Jin GY, Han YM, Chung GH, Lee YC, Kwon KS, Lynch D.
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):343-50. PubMed ID: 21626257
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
    Kim BH, Kim HJ, Wu HG, Kang CH, Kim YT, Lee SH, Kim DW.
    Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
    [Abstract] [Full Text] [Related]

  • 16. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.
    Lachmann PJ, Grant RM, Freedman LS, Sikora K, Bleehen NM.
    Br J Cancer; 1985 Mar; 51(3):415-7. PubMed ID: 3882114
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).
    Schild SE, Hillman SL, Tan AD, Ross HJ, McGinnis WL, Garces YA, Graham DL, Adjei AA, Jett JR, Mayo Clinic, North Central Cancer Treatment Group.
    J Thorac Oncol; 2017 Apr; 12(4):697-703. PubMed ID: 28089762
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
    Ogura T.
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.